Innovating Works

GATE2BRAIN SL

Activa
G2B-002: GATE2BRAIN TOWARDS SME DESIGNATION AND PAEDIATRIC INVESTIGATIONAL PLAN GATE2BRAIN SL tramitó un HORIZON EUROPE: Gate2Brain (G2B) is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier (BBB). Using this radically innovative pepti...
2023-07-20 | Financiado
Gate2Brain: Gate2Brain. Medicines beyond barriers. GATE2BRAIN SL tramitó un HORIZON EUROPE: In 2019, 30 million people worldwide were diagnosed with some form of CNS disorder and most of them lack effective treatment. This is largely explained by the fact that most of developed therapeutic m...
2023-03-16 | Financiado
DIN2021-011811: Gate2Brain, una puerta para el transporte de fármacos al cerebro GATE2BRAIN SL tramitó un AEI: DOCTORADOS INDUSTRIALES 21 2021-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.